AXS-06

9 stories · following the connections

Business

Axsome Therapeutics Announces AXS-06 (MoSEIC™ Meloxicam and Esomeprazole) Meets Primary Endpoint in Phase 1 Clinical Trial

By Nasdaq OMXJul 25, 2017, 11:01 AM UTC